Product Images Lumoxiti

This is a cautionary message regarding the use of a specific solution stabilizer product with LUMoXITI. The text emphasizes that the solution stabilizer should not be directly used for reconstitution of LUMoXITI.*

This text indicates that there is a solution stabilizer available for LUMOXITI®, but it should not be used for directly reconstituting the medication.*

This is a medication called DLUMOXITI, with NDC code 0310-4700-01, which contains moxetumomab pasudotox-tdfk and is for intravenous infusion only after reconstitution and dilution. It is important to use an IV Solution Stabilizer for LUMOXITI, packaged separately, to prepare the infusion bag before adding reconstituted LUMOXITI. There are no preservatives in this medication and the vial should be kept in its original carton to protect from light. Medication guide should be given to each patient. This drug comes in a single-dose vial and any unused portion should be discarded.*

LUMoXITI® is a medication that requires injection and is intended only for intravenous infusion after reconstitution and dilution. Its active ingredient is tumomab pasudotox. This text does not provide any further details about the drug's indications or uses.*

This is a sterile solution of water for injection that meets the standards of US Pharmacopeia. It can be used for various medical purposes that require sterile water, such as diluting medications or for wound irrigation.*

LumoxiTi is a drug that is administered through intravenous infusion after it is reconstituted and diluted. The drug's full name is moxetumomab pasudotox-tdfk.*

Lumoxiti® is a medication that is administered by intravenous infusion only, and is used after reconstitution and dilution. The medication's full name is moxetumomab pasudotox-tdfk.*